Meningococcal vaccine and haemophilus b vaccine Intramuscular and Zykadia

• Generic Name: haemophilus b conjugate (prp-t) vaccine / meningococcal conjugate vaccine
• Dosage Forms: n.a.
• Other Brand Names: MenHibrix

Meningococcal polysaccharide vaccine and Haemophilus B conjugate vaccine is an active immunizing combination agent that is used to prevent infection caused by certain groups of meningococcal bacteria and Haemophilus influenza type b (Hib) bacteria. The vaccine works by causing your body to produce its own protection (antibodies) against the disease.

The following information applies only to the meningococcal vaccine used for meningococcal bacteria Groups C and Y

Menhibrix vaccine is recommended for use in children 6 weeks to 18 months of age.

This vaccine is to be administered only by or under the direct supervision of your doctor.

• Generic Name: ceritinib
• Dosage Forms: capsule
• Other Brand Names: Zykadia

Zykadia (ceritinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Zykadia is used to treat non-small cell lung cancer that has spread to other parts of the body.

Zykadia is used only if your cancer has a specific genetic marker. Your doctor will test you for this gene.